Zhong Shanshan indirectly backed DeepSeek through his investment vehicle, with the stake estimated at about RMB 354 million
DeepSeek’s first financing round is drawing renewed attention as the company moves into a second round, with more details emerging about who got in early. Public ownership records cited in the report show that Zhong Shanshan, China’s richest man and founder behind the Nongfu Spring and Wantai Bio businesses, indirectly invested in DeepSeek through a chain of entities linked to Guanzi Venture Capital. Based on the structure described in the article and Tianyancha corporate data, the investment is estimated at roughly RMB 354 million. The report says DeepSeek’s first round, completed in June, included state-backed capital, market-oriented institutions, internet companies, and a RMB 5 billion commitment from CATL. It also names industrial capital from firms such as Andon Health, By-Health, and Septwolves. For Zhong, the DeepSeek deal stands out because it is described as his first move into the AI large-model segment, even though Guanzi Venture Capital had previously appeared as a pre-IPO shareholder in AI chip company Lightelligence. The article also maps a broader technology investment footprint under the Yangshengtang system, including Qiantang New Materials Laboratory and the Kunshan Gewu Zhizhi fund, both of which have been active in hard-tech areas such as new materials, photonic chips, superconducting equipment, embodied intelligence, and solid-state batteries.








